From: Refractive corneal inlay for presbyopia in emmetropic patients in Asia: 6-month clinical outcomes
 | Preoperative | 1 month | 3 months | 6 months | |
---|---|---|---|---|---|
Operated eyes | UNVA | 0.55 ± 0.22 | 0.26 ± 0.19* | 0.25 ± 0.14* | 0.25 ± 0.15* |
UIVA | 0.26 ± 0.19 | 0.27 ± 0.17 | 0.27 ± 0.18 | 0.24 ± 0.13 | |
UDVA | 0.01 ± 0.04 | 0.39 ± 0.21* | 0.30 ± 0.18* | 0.32 ± 0.14* | |
CDVA | −0.02 ± 0.05 | 0.19 ± 0.13* | 0.14 ± 0.12* | 0.11 ± 0.10* | |
Bilateral | UNVA | 0.35 ± 0.10 | 0.17 ± 0.11* | 0.16 ± 0.08* | 0.17 ± 0.11* |
UIVA | 0.14 ± 0.12 | 0.09 ± 0.10 | 0.10 ± 0.11 | 0.07 ± 0.11 | |
UDVA | −0.04 ± 0.07 | −0.03 ± 0.09 | − 0.07 ± 0.08 | −0.07 ± 0.11 |